De-risking rejuvenation therapy could be seismic Shift for longevity
Discover more about Shift Bioscience ahead of Daniel Ive’s presentation at Master Investor’s Investing in the Age of Longevity event.
Discover more about Shift Bioscience ahead of Daniel Ive’s presentation at Master Investor’s Investing in the Age of Longevity event.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Mark Watson-Mitchell proves a quick round-up of three previous profile stocks for the start of the week.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
The purpose of COP26 was to formulate initiatives that would decelerate global warming and make the politicians feel good about themselves.
Mark Watson-Mitchell takes a look at the prospects of window and door manufacturer Safestyle UK ahead of its trading update.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Robert Stephens, CFA, discusses the prospects for two FTSE 350 real estate investment trusts (REITs)
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.